Literature DB >> 7770740

Schizotypal personality disorder in parents and the risk for schizophrenia in siblings.

K S Kendler1, D Walsh.   

Abstract

With on exception, previous studies examining the familial relationship between schizotypal personality disorder (SPD) and schizophrenia have compared rates of SPD in relatives of probands with schizophrenia versus control probands. In the Roscommon Family Study, an epidemiologically based family study of major psychiatric disorders conducted in the west of Ireland, we used a Cox proportional hazards model to examine the impact of a parental diagnosis of SPD on the risk for psychiatric disorders in siblings of probands with schizophrenia or schizophrenia spectrum disorders. In siblings of probands with schizophrenia or schizophrenia spectrum, a parental diagnosis of SPD significantly increased the risk for schizophrenia and schizophrenia spectrum disorders, but not for affective illness or anxiety disorders. These findings replicate our previous results from the Roscommon Family Study, further supporting the hypothesis that SPD has a substantial familial relationship with schizophrenia and other schizophrenia spectrum disorders, but not with affective illness.

Entities:  

Mesh:

Year:  1995        PMID: 7770740     DOI: 10.1093/schbul/21.1.47

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  10 in total

1.  Large CSF volume not attributable to ventricular volume in schizotypal personality disorder.

Authors:  C C Dickey; M E Shenton; Y Hirayasu; I Fischer; M M Voglmaier; M A Niznikiewicz; L J Seidman; S Fraone; R W McCarley
Journal:  Am J Psychiatry       Date:  2000-01       Impact factor: 18.112

Review 2.  The brain in schizotypal personality disorder: a review of structural MRI and CT findings.

Authors:  Chandlee C Dickey; Robert W McCarley; Martha E Shenton
Journal:  Harv Rev Psychiatry       Date:  2002 Jan-Feb       Impact factor: 3.732

3.  Does unwantedness of pregnancy predict schizophrenia in the offspring? Findings from a prospective birth cohort study.

Authors:  Daniel B Herman; Alan S Brown; Mark G Opler; Manisha Desai; Dolores Malaspina; Michaeline Bresnahan; Catherine A Schaefer; Ezra S Susser
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2006-05-26       Impact factor: 4.328

4.  Sex versus gender differences in schizophrenia: The case for normal personality differences.

Authors:  Richard Lewine; Morgan Martin; Mara Hart
Journal:  Schizophr Res       Date:  2017-02-16       Impact factor: 4.939

5.  Paternal age and risk of schizophrenia in adult offspring.

Authors:  Alan S Brown; Catherine A Schaefer; Richard J Wyatt; Melissa D Begg; Raymond Goetz; Michaeline A Bresnahan; Jill Harkavy-Friedman; Jack M Gorman; Dolores Malaspina; Ezra S Susser
Journal:  Am J Psychiatry       Date:  2002-09       Impact factor: 18.112

6.  Neural mechanisms of smooth pursuit eye movements in schizotypy.

Authors:  Inga Meyhöfer; Maria Steffens; Anna Kasparbauer; Phillip Grant; Bernd Weber; Ulrich Ettinger
Journal:  Hum Brain Mapp       Date:  2014-09-05       Impact factor: 5.038

7.  Substantial genetic overlap between schizotypy and neuroticism: a twin study.

Authors:  Christine Macare; Timothy C Bates; Andrew C Heath; Nicholas G Martin; Ulrich Ettinger
Journal:  Behav Genet       Date:  2012-09-07       Impact factor: 2.805

8.  Association of Substance Use Disorders With Conversion From Schizotypal Disorder to Schizophrenia.

Authors:  Carsten Hjorthøj; Nikolai Albert; Merete Nordentoft
Journal:  JAMA Psychiatry       Date:  2018-07-01       Impact factor: 21.596

Review 9.  The role of schizotypy in the study of the etiology of schizophrenia spectrum disorders.

Authors:  Neus Barrantes-Vidal; Phillip Grant; Thomas R Kwapil
Journal:  Schizophr Bull       Date:  2015-03       Impact factor: 9.306

Review 10.  Is Schizotypy per se a Suitable Endophenotype of Schizophrenia? - Do Not Forget to Distinguish Positive from Negative Facets.

Authors:  Phillip Grant
Journal:  Front Psychiatry       Date:  2015-10-23       Impact factor: 4.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.